Status:
COMPLETED
Immunodeficiency for Severe Epstein-Barr Virus Infection
Lead Sponsor:
Children's Hospital of Fudan University
Conditions:
Epstein-Barr Virus Infections
Immunodeficiency
Eligibility:
All Genders
1-18 years
Brief Summary
The purpose of this study is to investigate the immune responses associated with Epstein-Barr virus infections, and to find out the possible immunodeficiency that may be linked to severe Epstein-Barr ...
Detailed Description
Epstein-Barr virus (EBV) belongs to herpesviridae family, which infects more than 90% of the population. EBV infection is usually asymptomatic and establishes lifelong persistence in the host, althoug...
Eligibility Criteria
Inclusion
- 1\. Age：birth to 18 years 2. Severe Epstein-Barr Virus infection
Exclusion
- 1\. Lack of parental consent
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03374566
Start Date
December 1 2017
End Date
February 1 2023
Last Update
February 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China